Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical …

A Shariati, M Dadashi, MT Moghadam, A van Belkum… - Scientific reports, 2020 - nature.com
Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-intermediate S. aureus
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …

Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus …

S Zhang, X Sun, W Chang, Y Dai, X Ma - PloS one, 2015 - journals.plos.org
Background Vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous
VISA (hVISA) are associated with vancomycin treatment failure, and are becoming an …

Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India

YD Bakthavatchalam, P Babu, E Munusamy… - PLoS …, 2019 - journals.plos.org
Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important clinical
concern in patients, and is often associated with significant disease burden and metastatic …

Antimicrobial susceptibility profile & resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India

B Veeraraghavan, K Walia - Indian Journal of Medical Research, 2019 - journals.lww.com
Antimicrobial resistance is a major concern globally. Infections due to drug-resistant
pathogens are becoming difficult and a challenge to treat. As treatment choices are limited …

[HTML][HTML] Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings

AM Spagnolo, P Orlando, D Panatto… - Journal of preventive …, 2014 - ncbi.nlm.nih.gov
Glycopeptide resistance in Staphylococcus aureus is a source of great concern because,
especially in hospitals, this class of antibiotics, particularly vancomycin, is one of the main …

Vancomycin and linezolid resistance among multidrug-resistant Staphylococcus aureus clinical isolates and interaction with neutrophils

ASJ Al-Bdery, GJ Mohammad, B Hussen - Gene Reports, 2020 - Elsevier
Background Developed drug resistance against vancomycin and linezolid is a huge
worrisome. The aim of our study was to investigate the rate of vancomycin and linezolid …

Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: a preliminary report from south India

R Amberpet, S Sistla, M Sugumar… - Indian Journal of …, 2019 - journals.lww.com
Methods: BHIV4 and PAP-AUC methods were employed to detect hVISA among 500 clinical
isolates of MRSA. SCCmec typing of these isolates was performed by multiplex polymerase …

Pneumonia caused by methicillin-resistant Staphylococcus aureus: does vancomycin heteroresistance matter?

KC Claeys, AM Lagnf, JA Hallesy… - Antimicrobial agents …, 2016 - Am Soc Microbiol
Vancomycin remains the mainstay treatment for methicillin-resistant Staphylococcus aureus
(MRSA) infections, including pneumonia. There is concern regarding the emergence of …

Recent pattern of antibiotic resistance in Staphylococcus aureus clinical isolates in Eastern India and the emergence of reduced susceptibility to vancomycin

S Mohanty, B Behera, S Sahu… - Journal of Laboratory …, 2019 - thieme-connect.com
PURPOSE: We aimed to determine the recent pattern of antibiotic resistance and assess the
vancomycin susceptibility profile of clinical Staphylococcus aureus in view of emerging …

Investigation of the VISA and hVISA Presence in Methicillin-Resistant Staphylococcus aureus Isolates by Various Methods

Ş Uçar, Y Duman, E Tanrıverdi… - Mikrobiyoloji …, 2022 - avesis.inonu.edu.tr
Staphylococcus aureus toplum ve hastane kaynaklı enfeksiyonlara yol açan önemli bir insan
patojenidir. Metisiline dirençli S. aureus (MRSA) enfeksiyonlarının tedavisinde vankomisinin …